Gaining Ground: Pediatrix Medical Group Inc (MD) Closes Lower at 6.89, Down -3.64

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of Pediatrix Medical Group Inc (NYSE: MD) closed at $6.89 in the last session, down -3.64% from day before closing price of $7.15. In other words, the price has decreased by -$3.64 from its previous closing price. On the day, 1.26 million shares were traded. MD stock price reached its highest trading level at $7.25 during the session, while it also had its lowest trading level at $6.89.


We take a closer look at MD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.13. For the most recent quarter (mrq), Quick Ratio is recorded 1.72 and its Current Ratio is at 1.72. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.87.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, SVB Leerink on September 27, 2021, initiated with a Mkt Perform rating and assigned the stock a target price of $29.

Deutsche Bank Downgraded its Hold to Sell on October 19, 2020, whereas the target price for the stock was revised from $20 to $12.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 14 ’23 when Swift James D sold 5,764 shares for $9.58 per share. The transaction valued at 55,219 led to the insider holds 90,874 shares of the business.

Moore Mary Ann E sold 1,150 shares of MD for $11,063 on Dec 14 ’23. The EVP, General Counsel & Sec now owns 15,730 shares after completing the transaction at $9.62 per share. On Dec 14 ’23, another insider, Moore Mary Ann E, who serves as the EVP, General Counsel & Sec of the company, sold 970 shares for $9.62 each. As a result, the insider received 9,331 and left with 81,385 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 601652672 and an Enterprise Value of 1233616000. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at 0.617 whereas that against EBITDA is 6.503.

Stock Price History:

Over the past 52 weeks, MD has reached a high of $15.02, while it has fallen to a 52-week low of $7.02. The 50-Day Moving Average of the stock is -20.30%, while the 200-Day Moving Average is calculated to be -31.26%.

Shares Statistics:

According to the various share statistics, MD traded on average about 893.69K shares per day over the past 3-months and 1653600 shares per day over the past 10 days. A total of 84.02M shares are outstanding, with a floating share count of 83.20M. Insiders hold about 1.13% of the company’s shares, while institutions hold 102.12% stake in the company. Shares short for MD as of 1715731200 were 4410895 with a Short Ratio of 4.94, compared to 1713139200 on 4602543. Therefore, it implies a Short% of Shares Outstanding of 4410895 and a Short% of Float of 7.4499995.

Most Popular